270 related articles for article (PubMed ID: 16126724)
21. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM
Nature; 2001 Sep; 413(6852):131-8. PubMed ID: 11557972
[TBL] [Abstract][Full Text] [Related]
22. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
Wu C; Khan SA; Peng LJ; Li H; Carmella SG; Lange AJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E536-43. PubMed ID: 16621898
[TBL] [Abstract][Full Text] [Related]
23. The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes.
Arizmendi C; Liu S; Croniger C; Poli V; Friedman JE
J Biol Chem; 1999 May; 274(19):13033-40. PubMed ID: 10224054
[TBL] [Abstract][Full Text] [Related]
24. Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation.
Quinn PG; Yeagley D
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):423-37. PubMed ID: 16375695
[TBL] [Abstract][Full Text] [Related]
25. Activities of key gluconeogenic enzymes and glycogen synthase in rat and human livers, hepatomas, and hepatoma cell cultures.
Hammond KD; Balinsky D
Cancer Res; 1978 May; 38(5):1317-22. PubMed ID: 205362
[TBL] [Abstract][Full Text] [Related]
26. Vanadate normalizes hyperglycemia and phosphoenolpyruvate carboxykinase mRNA levels in ob/ob mice.
Ferber S; Meyerovitch J; Kriauciunas KM; Kahn CR
Metabolism; 1994 Nov; 43(11):1346-54. PubMed ID: 7968588
[TBL] [Abstract][Full Text] [Related]
27. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase.
Lochhead PA; Salt IP; Walker KS; Hardie DG; Sutherland C
Diabetes; 2000 Jun; 49(6):896-903. PubMed ID: 10866040
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
29. Peroxisome proliferator-activated receptor gamma coactivator-1alpha, as a transcription amplifier, is not essential for basal and hormone-induced phosphoenolpyruvate carboxykinase gene expression.
Herzog B; Hall RK; Wang XL; Waltner-Law M; Granner DK
Mol Endocrinol; 2004 Apr; 18(4):807-19. PubMed ID: 15044597
[TBL] [Abstract][Full Text] [Related]
30. Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases cAMP-stimulated hepatic gluconeogenesis via inhibition of CREB.
Seo HY; Kim MK; Min AK; Kim HS; Ryu SY; Kim NK; Lee KM; Kim HJ; Choi HS; Lee KU; Park KG; Lee IK
Endocrinology; 2010 Feb; 151(2):561-8. PubMed ID: 20022930
[TBL] [Abstract][Full Text] [Related]
31. Tumour necrosis factor-alpha attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells.
Pandey AK; Bhardwaj V; Datta M
FEBS J; 2009 Jul; 276(14):3757-69. PubMed ID: 19769745
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
Lochhead PA; Coghlan M; Rice SQ; Sutherland C
Diabetes; 2001 May; 50(5):937-46. PubMed ID: 11334436
[TBL] [Abstract][Full Text] [Related]
33. Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect.
Hall RK; Wang XL; George L; Koch SR; Granner DK
Mol Endocrinol; 2007 Feb; 21(2):550-63. PubMed ID: 17095578
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells.
Barthel A; Schmoll D; Krüger KD; Bahrenberg G; Walther R; Roth RA; Joost HG
Biochem Biophys Res Commun; 2001 Jul; 285(4):897-902. PubMed ID: 11467835
[TBL] [Abstract][Full Text] [Related]
35. Lithium inhibits hepatic gluconeogenesis and phosphoenolpyruvate carboxykinase gene expression.
Bosch F; Rodriguez-Gil JE; Hatzoglou M; Gomez-Foix AM; Hanson RW
J Biol Chem; 1992 Feb; 267(5):2888-93. PubMed ID: 1371108
[TBL] [Abstract][Full Text] [Related]
36. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
37. Control of gluconeogenic genes during intense/prolonged exercise: hormone-independent effect of muscle-derived IL-6 on hepatic tissue and PEPCK mRNA.
Banzet S; Koulmann N; Simler N; Sanchez H; Chapot R; Serrurier B; Peinnequin A; Bigard X
J Appl Physiol (1985); 2009 Dec; 107(6):1830-9. PubMed ID: 19850730
[TBL] [Abstract][Full Text] [Related]
38. The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism.
Scott DK; O'Doherty RM; Stafford JM; Newgard CB; Granner DK
J Biol Chem; 1998 Sep; 273(37):24145-51. PubMed ID: 9727036
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.
Li X; Xu M; Wang F; Kohan AB; Haas MK; Yang Q; Lou D; Obici S; Davidson WS; Tso P
J Biol Chem; 2014 Jan; 289(4):2396-404. PubMed ID: 24311788
[TBL] [Abstract][Full Text] [Related]
40. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice.
Gómez-Valadés AG; Méndez-Lucas A; Vidal-Alabró A; Blasco FX; Chillon M; Bartrons R; Bermúdez J; Perales JC
Diabetes; 2008 Aug; 57(8):2199-210. PubMed ID: 18443203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
